ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention (Q37070174)

18 August 2017

ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention (English)

1 reference

18 August 2017

Christopher B. Granger

14

object named as

Christopher B Granger

1 reference

18 August 2017

13

William E Kraus

1 reference

18 August 2017

16

L Kristin Newby

1 reference

18 August 2017

Pascal J Goldschmidt-Clermont

15

object named as

Pascal Goldschmidt-Clermont

1 reference

18 August 2017

Svati H Shah

1

1 reference

18 August 2017

Elizabeth R Hauser

2

1 reference

18 August 2017

David Crosslin

3

1 reference

18 August 2017

Liyong Wang

4

1 reference

18 August 2017

Carol Haynes

5

1 reference

18 August 2017

Jessica Connelly

6

1 reference

18 August 2017

Sarah Nelson

7

1 reference

18 August 2017

Jessica Johnson

8

1 reference

18 August 2017

Shera Gadson

9

1 reference

18 August 2017

Charlotte L Nelson

10

1 reference

18 August 2017

David Seo

11

1 reference

18 August 2017

Simon Gregory

12

1 reference

18 August 2017

language of work or name

1 reference

12 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

201

1 reference

18 August 2017

1

1 reference

18 August 2017

148-154

1 reference

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

Molecular evidence for arterial repair in atherosclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

Decision models for assessing the cost effectiveness of drug-eluting stents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

Coronary in-stent restenosis: current status and future strategies.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

An HphI polymorphism in the E-selectin gene is associated with premature coronary artery disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

Mechanism of inhibitory action of tranilast on the release of slow reacting substance of anaphylaxis (SRS-A) in vitro: effect of tranilast on the release of arachidonic acid and its metabolites

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

Stent-based local delivery of nuclear factor-kappaB decoy attenuates in-stent restenosis in hypercholesterolemic rabbits.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3733458

Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting

4 December 2018

1 reference

12 December 2020

Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit

1 reference

12 December 2020

Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting

1 reference

12 December 2020

The endothelial nitric oxide synthase (Glu298Asp and –786T>C) gene polymorphisms are associated with coronary in-stent restenosis

1 reference

12 December 2020

Gene expression phenotypes of atherosclerosis

1 reference

12 December 2020

Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery

1 reference

12 December 2020

Tranilast suppresses intimal hyperplasia in the balloon injury model and cuff treatment model in rabbits

1 reference

12 December 2020

Predictive factors of restenosis after coronary stent placement

1 reference

12 December 2020

Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis

1 reference

12 December 2020

10.1016/J.ATHEROSCLEROSIS.2008.01.011

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

18374923

1 reference